Procter & Gamble Earnings: Sales Trend Higher on Continued Brand Spending
We believe P&G stock remains overvalued.

Key Morningstar Metrics for Procter & Gamble
- Fair Value Estimate: $143.00
- Morningstar Rating: ★★
- Morningstar Economic Moat Rating: Wide
- Morningstar Uncertainty Rating: Low
What We Thought of Procter & Gamble’s Earnings
Procter & Gamble PG posted a 3% rise in organic sales on a 2% bump in volumes and a 1% benefit from favorable mix. However, margins contracted, with the firm’s adjusted gross margin down 30 basis points to 52.4% and its adjusted operating margin off 80 basis points to 26.2%.
Why it matters: Even in the face of macro, geopolitical, and competitive headwinds, P&G continues to invest in consumer-valued innovation and marketing to ensure its products win at the shelf for retailers and consumers.
- We don’t expect P&G will divert from this course, as we forecast it will funnel 13% of sales (more than $13 billion annually) on average annually to R&D and marketing over our 10-year forecast.
- To fund investments in its brands and capabilities, we expect P&G will scour the business to drive savings by reducing overhead, lowering material costs, and increasing productivity.
The bottom line: Our fair value estimate of $143 per share P&G holds, as results through the first half of the fiscal year and guidance continue to align with our full-year outlook for 3.6% organic sales growth, and nearly 6% growth in adjusted earnings per share.
- While shares look heated, trading 20% above our valuation, we think this name should remain on investors’ radars to the extent angst around competition and a waning macro landscape dent the share price.
Between the lines: The tide appears to be turning for P&G in its second-largest market, China (10% of sales by our estimate), where organic sales slipped a mere 3% in the quarter—a far cry from the 15% decline chalked up in the prior quarter.
- The gains were particularly notable in its premium skincare brand, SK-II, which boasted 5% organic sales growth, versus a 20% retreat in the first fiscal quarter.
- We attribute this improvement to diligent investments behind its brands and capabilities supporting its competitive position and brand prowess, despite tepid consumer confidence and anti-Japanese sentiment around SK-II.
Procter & Gamble Stock vs. Morningstar Fair Value Estimate
The author or authors do not own shares in any securities mentioned in this article. Find out about Morningstar’s editorial policies.
